Parkinson's disease: Evidence for environmental risk factors.
- Published in:
- Movement Disorders, 2013, v. 28, n. 1, p. 8, doi. 10.1002/mds.25150
- By:
- Publication type:
- Article
Works matching IS 08853185 AND DT 2013 AND VI 28 AND IP 1
Results: 13
1
2
Cell Therapy for Parkinson's Disease: What Next?
- Published in:
- Movement Disorders, 2013, v. 28, n. 1, p. 110, doi. 10.1002/mds.25343
- By:
- Publication type:
- Article
3
Pathogenesis of Parkinson's disease.
- Published in:
- Movement Disorders, 2013, v. 28, n. 1, p. 24, doi. 10.1002/mds.25032
- By:
- Publication type:
- Article
4
New synaptic and molecular targets for neuroprotection in Parkinson's disease.
- Published in:
- Movement Disorders, 2013, v. 28, n. 1, p. 51, doi. 10.1002/mds.25096
- By:
- Publication type:
- Article
5
Animal models of Parkinson's disease: Limits and relevance to neuroprotection studies.
- Published in:
- Movement Disorders, 2013, v. 28, n. 1, p. 61, doi. 10.1002/mds.25108
- By:
- Publication type:
- Article
6
Neuronal vulnerability, pathogenesis, and Parkinson's disease.
- Published in:
- Movement Disorders, 2013, v. 28, n. 1, p. 41, doi. 10.1002/mds.25095
- By:
- Publication type:
- Article
7
Parkinson's Disease and Alpha Synuclein: Is Parkinson's Disease a Prion-Like Disorder?
- Published in:
- Movement Disorders, 2013, v. 28, n. 1, p. 31, doi. 10.1002/mds.25373
- By:
- Publication type:
- Article
8
Trophic Factor Gene Therapy for Parkinson's Disease.
- Published in:
- Movement Disorders, 2013, v. 28, n. 1, p. 96, doi. 10.1002/mds.25344
- By:
- Publication type:
- Article
9
Obstacles to the Development of a Neuroprotective Therapy for Parkinson's Disease.
- Published in:
- Movement Disorders, 2013, v. 28, n. 1, p. 3, doi. 10.1002/mds.25337
- By:
- Publication type:
- Article
10
Trial designs used to study neuroprotective therapy in Parkinson's disease.
- Published in:
- Movement Disorders, 2013, v. 28, n. 1, p. 86, doi. 10.1002/mds.24997
- By:
- Publication type:
- Article
11
The genetics of Parkinson's disease: Progress and therapeutic implications.
- Published in:
- Movement Disorders, 2013, v. 28, n. 1, p. 14, doi. 10.1002/mds.25249
- By:
- Publication type:
- Article
12
Biomarkers for trials of neuroprotection in Parkinson's disease.
- Published in:
- Movement Disorders, 2013, v. 28, n. 1, p. 71, doi. 10.1002/mds.25065
- By:
- Publication type:
- Article
13
The Vatican Meeting on Neuroprotection for Parkinson's Disease.
- Published in:
- Movement Disorders, 2013, v. 28, n. 1, p. 1, doi. 10.1002/mds.25356
- By:
- Publication type:
- Article